NFE2L2 and hypersensitivity pneumonitis: Reduced the levels of α-SMA, MDA; increased the levels of E-cadherin, Nrf2, HO−1, SOD, and GSH; mitigated alveolitis severity, relieved fibrosis scores, inhibited the increase in the myofibroblasts–like processes of the AECs.